{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T13:31:20Z","timestamp":1768311080521,"version":"3.49.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"S4","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1186\/s12859-017-1522-2","type":"journal-article","created":{"date-parts":[[2017,3,22]],"date-time":"2017-03-22T10:24:20Z","timestamp":1490178260000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Towards targeted combinatorial therapy design for the treatment of castration-resistant prostate cancer"],"prefix":"10.1186","volume":"18","author":[{"given":"Osama Ali","family":"Arshad","sequence":"first","affiliation":[]},{"given":"Aniruddha","family":"Datta","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2017,3,22]]},"reference":[{"key":"1522_CR1","first-page":"5","volume":"65","author":"RL Siegel","year":"2015","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics 2015. CA: a cancer journal for clinicians. 2015; 65:5\u201329.","journal-title":"CA: a cancer journal for clinicians"},{"key":"1522_CR2","doi-asserted-by":"crossref","unstructured":"Feng J, Zheng SL, Liu W, Isaacs WB, Xu J. Androgen receptor signaling in prostate cancer: new twists for an old pathway. J Steroids Hormon Sci. 2011.","DOI":"10.4172\/2157-7536.S2-001"},{"issue":"11","key":"1522_CR3","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/nrurol.2012.185","volume":"9","author":"LK Boyd","year":"2012","unstructured":"Boyd LK, Mao X, Lu YJ. The complexity of prostate cancer: genomic alterations and heterogeneity. Nat Rev Urol. 2012; 9(11):652\u201364.","journal-title":"Nat Rev Urol"},{"issue":"7","key":"1522_CR4","first-page":"620","volume":"27","author":"CL Derleth","year":"2013","unstructured":"Derleth CL, Evan YY. Targeted therapy in the treatment of castration-resistant prostate cancer. Oncology. 2013; 27(7):620\u201330.","journal-title":"Oncology"},{"issue":"2","key":"1522_CR5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000323581","volume":"57","author":"S Leo","year":"2010","unstructured":"Leo S, Accettura C, Lorusso V. Castration-resistant prostate cancer: targeted therapies. Chemotherapy. 2010; 57(2):115\u201327.","journal-title":"Chemotherapy"},{"key":"1522_CR6","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S1470-2045(09)70229-3","volume":"10","author":"Y Chen","year":"2009","unstructured":"Chen Y, Clegg NJ, Scher HI. Anti-androgens and androgen-depleting therapies in prostate cancer: new agents for an established target. Lancet Oncol. 2009; 10:981\u201391.","journal-title":"Lancet Oncol"},{"key":"1522_CR7","volume-title":"Batten AM","author":"JC Patel","year":"2013","unstructured":"Patel JC, Maughan BL, Agarwal AM. Batten AM. Zhang TY: Agarwal N. Emerging molecularly targeted therapies in castration refractory prostate cancer. Prostate Cancer; 2013."},{"issue":"5","key":"1522_CR8","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.eururo.2011.12.028","volume":"61","author":"N Agarwal","year":"2012","unstructured":"Agarwal N, Sonpavde G, Sternberg CN. Novel molecular targets for the therapy of castration-resistant prostate cancer. Eur Urol. 2012; 61(5):950\u201360.","journal-title":"Eur Urol"},{"issue":"3","key":"1522_CR9","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1634\/theoncologist.2010-0216","volume":"16","author":"R Aggarwal","year":"2011","unstructured":"Aggarwal R, Ryan CJ. Castration-resistant prostate cancer: targeted therapies and individualized treatment. Oncologist. 2011; 16(3):264\u201375.","journal-title":"Oncologist"},{"key":"1522_CR10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4236\/jbise.2013.62A027","volume":"6","author":"V Nedumparambathmarath","year":"2013","unstructured":"Nedumparambathmarath V, Chakrabarti SK, Sreekumar J. Modeling of gene regulatory networks: a review. J Biomed Sci Eng. 2013; 6:223\u201331.","journal-title":"J Biomed Sci Eng"},{"key":"1522_CR11","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780195079517.001.0001","volume-title":"The origins of order: self-organization and selection in evolution","author":"SA Kaufmann","year":"1993","unstructured":"Kaufmann SA. The origins of order: self-organization and selection in evolution. New York:Oxford University Press; 1993."},{"issue":"6","key":"1522_CR12","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1073\/pnas.0705088105","volume":"105","author":"T Helikar","year":"2008","unstructured":"Helikar T, Konvalina J, Heidel J, Rogers JA. Emergent decision-making in biological signal transduction networks. Proc Natl Acad Sci. 2008; 105(6):1913\u20138.","journal-title":"Proc Natl Acad Sci"},{"key":"1522_CR13","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/wsbm.1273","volume":"6","author":"R Albert","year":"2014","unstructured":"Albert R, Thakar J. Boolean modeling: a logic-based dynamic approach for understanding signaling and regulatory networks and for making useful predictions. Wiley Interdiscip Rev Syst Biol Med. 2014; 6:353\u201369.","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"key":"1522_CR14","doi-asserted-by":"crossref","unstructured":"Wang R, Saadatpour A, Albert R. Boolean modeling in systems biology: an overview of methodology and applications. Phys Biol. 2012;9(5).","DOI":"10.1088\/1478-3975\/9\/5\/055001"},{"issue":"14","key":"1522_CR15","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1093\/bioinformatics\/btl210","volume":"22","author":"A Faur\u00e9","year":"2006","unstructured":"Faur\u00e9 A, Naldi A, Chaouiya C, Thieffry D. Dynamical analysis of a generic Boolean model for the control of the mammalian cell cycle. Bioinformatics. 2006; 22(14):e124\u2013e31.","journal-title":"Bioinformatics"},{"issue":"12","key":"1522_CR16","doi-asserted-by":"crossref","first-page":"e1000595","DOI":"10.1371\/journal.pcbi.1000595","volume":"5","author":"R Schlatter","year":"2009","unstructured":"Schlatter R, Schmich K, Vizcarra IA, Scheurich P, Sauter T, Borner C, Ederer M, Merfort I, Sawodny O. ON\/OFF and beyond-a Boolean model of apoptosis. PLoS Comput Biol. 2009; 5(12):e1000595.","journal-title":"PLoS Comput Biol"},{"issue":"42","key":"1522_CR17","doi-asserted-by":"crossref","first-page":"16308","DOI":"10.1073\/pnas.0806447105","volume":"105","author":"R Zhang","year":"2008","unstructured":"Zhang R, Shah MV, Yang J, Nyland SB, Liu X, Yun JK, Albert R, Loughran TP. Network model of survival signaling in large granular lymphocyte leukemia. Proc Natl Acad Sci. 2008; 105(42):16308\u201313.","journal-title":"Proc Natl Acad Sci"},{"key":"1522_CR18","unstructured":"Sridharan S, Varghese R, Venkatraj V, Datta A. Hypoxia stress response pathways: modeling and targeted therapy. IEEE J Biomed Health Inform. in press. http:\/\/ieeexplore.ieee.org\/document\/7460895\/ ."},{"issue":"9","key":"1522_CR19","doi-asserted-by":"crossref","first-page":"e1000936","DOI":"10.1371\/journal.pcbi.1000936","volume":"6","author":"CE Giacomantonio","year":"2010","unstructured":"Giacomantonio CE, Goodhill GJ. A Boolean model of the gene regulatory network underlying mammalian cortical area development. PLoS Comput Biol. 2010; 6(9):e1000936.","journal-title":"PLoS Comput Biol"},{"issue":"5","key":"1522_CR20","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ccr.2011.04.008","volume":"19","author":"BS Carver","year":"2011","unstructured":"Carver BS, Chapinski C, Wongvipat J, Hieronymus H, Chen Y, Chandarlapaty S, Arora VK, Le C, Koutcher J, Scher H, Scardino PT, Rosen N. Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer. Cancer Cell. 2011; 19(5):575\u201386.","journal-title":"Cancer Cell"},{"issue":"4","key":"1522_CR21","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1042\/BSR20120050","volume":"32","author":"HF Yuen","year":"2012","unstructured":"Yuen HF, Abramcyzk O, Montgomery G, Chan KK, Huang YH, Sasazuki T, Shirasawa S, Gopesh S, Chan KW, Fennell D, Janne P, El-Tanani M, Murray JT. Impact of oncogenic driver mutations on feedback between the PI3K and MEK pathways in cancer cells. Biosci Rep. 2012; 32(4):413\u201322.","journal-title":"Biosci Rep"},{"key":"1522_CR22","doi-asserted-by":"crossref","first-page":"D355","DOI":"10.1093\/nar\/gkp896","volume":"38","author":"M Kanehisa","year":"2010","unstructured":"Kanehisa M, Goto S, Furumichi M, Tanabe M, Hirakawa M. KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res. 2010; 38:D355\u2013D60.","journal-title":"Nucleic Acids Res"},{"key":"1522_CR23","doi-asserted-by":"crossref","first-page":"D354","DOI":"10.1093\/nar\/gkj102","volume":"34","author":"M Kanehisa","year":"2006","unstructured":"Kanehisa M, Goto S, Hattori M, Aoki-Kinoshita KF, Itoh M, Kawashima S, Katayama T, Araki M, Hirakawa M. From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res. 2006; 34:D354\u2013D7.","journal-title":"Nucleic Acids Res"},{"key":"1522_CR24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 2000; 28:27\u201330.","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"1522_CR25","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.drudis.2008.03.019","volume":"13","author":"S Watterson","year":"2008","unstructured":"Watterson S, Marshall S, Ghazal P. Logic models of pathway biology. Drug Discov Today. 2008; 13(9):447\u201356.","journal-title":"Drug Discov Today"},{"key":"1522_CR26","doi-asserted-by":"crossref","DOI":"10.1109\/9780470544389","volume-title":"Digital systems testing and testable design","author":"M Abramovici","year":"1994","unstructured":"Abramovici M, Breuer MA, Friedman AD. Digital systems testing and testable design. New York: Wiley-IEEE Press; 1994."},{"issue":"4","key":"1522_CR27","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/bioinformatics\/btq703","volume":"27","author":"R Layek","year":"2011","unstructured":"Layek R, Datta A, Bittner M, Dougherty E. Cancer therapy design based on pathway logic. Bioinformatics. 2011; 27(4):548\u201355.","journal-title":"Bioinformatics"},{"issue":"3","key":"1522_CR28","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1109\/TCAD.2009.2012530","volume":"28","author":"MR Choudhury","year":"2009","unstructured":"Choudhury MR, Mohanram K. Reliability analysis of logic circuits. Comput Aided Des Integr Circ Syst, IEEE Trans. 2009; 28(3):392\u2013405.","journal-title":"Comput Aided Des Integr Circ Syst, IEEE Trans"},{"issue":"6","key":"1522_CR29","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1109\/TC.2012.276","volume":"63","author":"J Han","year":"2014","unstructured":"Han J, Chen H, Liang J, Zhu P, Yang Z, Lombardi F. A stochastic computational approach for accurate and efficient reliability evaluation. IEEE Trans Comput. 2014; 63(6):1336\u201350.","journal-title":"IEEE Trans Comput"},{"issue":"42","key":"1522_CR30","doi-asserted-by":"crossref","first-page":"ra10","DOI":"10.1126\/scisignal.2000008","volume":"1","author":"A Abdi","year":"2008","unstructured":"Abdi A, Tahoori MB, Emamian ES. Fault Diagnosis Engineering of Digital Circuits Can Identify Vulnerable Molecules in Complex Cellular Pathways. Sci Signal. 2008; 1(42):ra10.","journal-title":"Sci Signal"},{"key":"1522_CR31","doi-asserted-by":"crossref","unstructured":"Zhu P, Aliabadi HM, Uluda\u011f H, Han J. Identification of Potential Drug Targets in Cancer Signaling Pathways using Stochastic Logical Models. Nat Sci Rep. 2016; 6.","DOI":"10.1038\/srep23078"},{"key":"1522_CR32","doi-asserted-by":"crossref","unstructured":"Liang J, Han J. Stochastic Boolean networks: an efficient approach to modeling gene regulatory networks. BMC Syst Biol. 2012; 6.","DOI":"10.1186\/1752-0509-6-113"},{"issue":"10","key":"1522_CR33","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1089\/cmb.2014.0057","volume":"21","author":"P Zhu","year":"2014","unstructured":"Zhu P, Han J. Asynchronous stochastic Boolean networks as gene network models. J Comput Biol. 2014; 21(10):771\u201383.","journal-title":"J Comput Biol"},{"issue":"6","key":"1522_CR34","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.eururo.2014.08.006","volume":"67","author":"P Toren","year":"2015","unstructured":"Toren P, Kim S, Cordonnier T, Crafter C, Davies BR, Fazli L, Gleave ME, Zoubeidi A. Combination AZD5363 with enzalutamide significantly delays enzalutamide-resistant prostate cancer in preclinical models. Eur Urol. 2015; 67(6):986\u201390.","journal-title":"Eur Urol"},{"issue":"15","key":"1522_CR35","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1002\/pros.23057","volume":"75","author":"H Park","year":"2015","unstructured":"Park H, Kim Y, Sul JW, Jeong IG, Yi HJ, Ahn JB, Kang JS, Yun J, Hwang JJ, Kim CS. Synergistic anticancer efficacy of MEK inhibition and dual PI3K\/mTOR inhibition in castration-resistant prostate cancer. Prostate. 2015; 75(15):1747\u201359.","journal-title":"Prostate"},{"key":"1522_CR36","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/1389450114666140106100909","volume":"15","author":"LM Dillon","year":"2014","unstructured":"Dillon LM, Miller TW. Therapeutic targeting of cancers with loss of PTEN function. Curr Drug Targets. 2014; 15:65\u201379.","journal-title":"Curr Drug Targets"},{"issue":"3","key":"1522_CR37","doi-asserted-by":"crossref","first-page":"R83","DOI":"10.1530\/ERC-12-0394","volume":"20","author":"RL Bitting","year":"2013","unstructured":"Bitting RL, Armstrong AJ. Targeting the PI3K\/Akt\/mTOR pathway in castration-resistant prostate cancer. Endocr relat Cancer. 2013; 20(3):R83\u2013R99.","journal-title":"Endocr relat Cancer"},{"issue":"15","key":"1522_CR38","doi-asserted-by":"crossref","first-page":"4799","DOI":"10.1158\/1078-0432.CCR-08-0125","volume":"15","author":"D Sarker","year":"2009","unstructured":"Sarker D, Reid AHM, Yap TA. de Bono JS. Targeting the PI3K\/AKT pathway for the treatment of prostate cancer. Clin Cancer Res. 2009; 15(15):4799\u2013805.","journal-title":"Clin Cancer Res"},{"key":"1522_CR39","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1155\/2010\/290643","volume":"32","author":"M Kaarb\u00f8","year":"2010","unstructured":"Kaarb\u00f8 M, Mikkelsen \u00d8L, Maler\u00f8d L, Qu S, Lobert VH, Akgul G, Halvorsen T, M\u00e6landsmo GM, Saatcioglu F. PI3K-AKT-mTOR pathway is dominant over androgen receptor signaling in prostate cancer cells. Anal Cell Pathol. 2010; 32:11\u201327.","journal-title":"Anal Cell Pathol"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-017-1522-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T05:11:10Z","timestamp":1719119470000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-017-1522-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":39,"journal-issue":{"issue":"S4","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["1522"],"URL":"https:\/\/doi.org\/10.1186\/s12859-017-1522-2","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3]]},"article-number":"134"}}